Evidence map›Paper›PMID 26621732›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Human autoreactive T cells recognize CD1b and phospholipids.

Ildiko Van Rhijn, Twan van Berlo, Tamara Hilmenyuk, Tan-Yun Cheng, Benjamin J Wolf, Raju V V Tatituri, Adam P Uldrich, Giorgio Napolitani, Vincenzo Cerundolo, John D Altman and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Novel Molecular Insights into Human Lipid-Mediated T Cell Immunity.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Human γδ T cells recognize CD1b by two distinct mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 4 countries.

Ildiko Van RhijnDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, The Netherlands; bmoody@partners.org mbrenner@partners.org i.vanrhijn@uu.nl.
Twan van BerloDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, The Netherlands;
Tamara HilmenyukDepartment of Microbiology & Immunology, Peter Doherty Institute, University of Melbourne, Parkville, VIC 3010, Australia; ARC Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia;
Tan-Yun ChengDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
Benjamin J WolfDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
Raju V V TatituriDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
Adam P UldrichDepartment of Microbiology & Immunology, Peter Doherty Institute, University of Melbourne, Parkville, VIC 3010, Australia; ARC Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia;
Giorgio NapolitaniMedical Research Council Human Immunology Unit, Radcliffe Department of Medicine, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom;
Vincenzo CerundoloMedical Research Council Human Immunology Unit, Radcliffe Department of Medicine, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom;
John D AltmanEmory Vaccine Center, Atlanta, GA 30329;
Peter WillemsenCentral Veterinary Institute, Wageningen University, 8219 PH Lelystad, The Netherlands;
Shouxiong HuangDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
Jamie RossjohnInfection and Immunity Program, Monash University, Wellington Road, Clayton, VIC 3800, Australia; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Wellington Road, Clayton, VIC 3800, Australia; ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Wellington Road, Clayton, VIC 3800, Australia; Institute of Infection and Immunity, Cardiff University, Cardiff CF10 3XQ, United Kingdom;
Gurdyal S BesraSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
Michael B BrennerDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; bmoody@partners.org mbrenner@partners.org i.vanrhijn@uu.nl.
Dale I GodfreyDepartment of Microbiology & Immunology, Peter Doherty Institute, University of Melbourne, Parkville, VIC 3010, Australia; ARC Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia;
D Branch MoodyDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; bmoody@partners.org mbrenner@partners.org i.vanrhijn@uu.nl.
Brigham and Women's Hospital · USHarvard University · USUniversity of Melbourne · AUUtrecht University · NLCardiff University · GBEmory Healthcare · USMRC Human Immunology Unit · GBPeter Doherty Institute · AUUniversity of Birmingham · GBUniversity of Oxford · GBWageningen University & Research · NL

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
The Next Generation Immunoanalysis CoreP30AR069625 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2016 to 2025
$8.8M
Regulatory iNKT Cells Suppress Inflammation and Drive ThermogenesisR01AI113046 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2014 to 2023
$3.9M
Cancer Research UK 17722Medical Research Council G1000800Medical Research Council G1001750Medical Research Council MC_UU_12010/1NIAID NIH HHS AI049313NIAID NIH HHS R01 AI049313NIAID NIH HHS R01 AI113046NIAID NIH HHS U19 AI111224NIAMS NIH HHS P30 AR069625
6 · The paper itself

Abstract

In contrast with the common detection of T cells that recognize MHC, CD1a, CD1c, or CD1d proteins, CD1b autoreactive T cells have been difficult to isolate in humans. Here we report the development of polyvalent complexes of CD1b proteins and carbohydrate backbones (dextramers) and their use in identifying CD1b autoreactive T cells from human donors. Activation is mediated by αβ T-cell receptors (TCRs) binding to CD1b-phospholipid complexes, which is sufficient to activate autoreactive responses to CD1b-expressing cells. Using mass spectrometry and T-cell responses to scan through the major classes of phospholipids, we identified phosphatidylglycerol (PG) as the immunodominant lipid antigen. T cells did not discriminate the chemical differences that distinguish mammalian PG from bacterial PG. Whereas most models of T-cell recognition emphasize TCR discrimination of differing self and foreign structures, CD1b autoreactive T cells recognize lipids with dual self and foreign origin. PG is rare in the cellular membranes that carry CD1b proteins. However, bacteria and mitochondria are rich in PG, so these data point to a more general mechanism of immune detection of infection- or stress-associated lipids.

Indexed as

Antigen-Presenting CellsAntigens, CD1HEK293 CellsHumansK562 CellsLymphocyte ActivationMass SpectrometryPhosphatidylglycerolsPhospholipidsT-LymphocytesTransfectionAntigens, CD1CD1b antigenPhosphatidylglycerolsPhospholipidsCD1bdendritic celllipid antigenself-antigenT cell

Identifiers

PMID26621732
PMCPMC4720340
OpenAlexW2196451278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.